HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Oshimi Selected Research

K Oshimi Research Topics

Disease

4Neoplasms (Cancer)
05/2008 - 08/2000
3Leukemia
05/2008 - 08/2000
2Lymphoma (Lymphomas)
08/2010 - 07/2000
1Starvation
08/2010
1Blast Crisis (Blast Phase)
06/2009
1Bacterial Meningitis
06/2009
1Necrosis
05/2008
1T-Cell Leukemia (Leukemia, T Cell)
06/2006
1Aneuploidy (Aneuploid)
06/2006
1Acute Erythroblastic Leukemia (Erythroleukemia)
08/2005
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
08/2005
1Large Granular Lymphocytic Leukemia
03/2004
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2001
1Prostatic Neoplasms (Prostate Cancer)
08/2001
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2001
1Ataxia Telangiectasia (Louis Bar Syndrome)
09/2000
1Graft vs Host Disease (Graft-Versus-Host Disease)
08/2000
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
04/2000
1Pleural Effusion (Pleural Effusions)
04/2000
1Brain Neoplasms (Brain Tumor)
02/2000
1Septic Shock (Toxic Shock Syndrome)
02/2000
1Hematologic Diseases (Blood Diseases)
02/2000
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
02/2000
1Infections
02/2000
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2000
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2000
1Dyspnea (Shortness of Breath)
01/2000
1Renal Insufficiency (Renal Failure)
01/2000

Drug/Important Bio-Agent (IBA)

3DNA (Deoxyribonucleic Acid)IBA
05/2008 - 07/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2008 - 09/2000
2Proteins (Proteins, Gene)FDA Link
06/2006 - 10/2001
2Antiphospholipid AntibodiesIBA
07/2001 - 02/2000
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
08/2010
1Antineoplastic Agents (Antineoplastics)IBA
08/2010
1geldanamycinIBA
05/2008
1NocodazoleIBA
06/2006
1Messenger RNA (mRNA)IBA
08/2005
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2001
1LigandsIBA
10/2001
1E-SelectinIBA
10/2001
1EstramustineFDA Link
08/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000
1Fas Ligand Protein (Fas Ligand)IBA
08/2000
1Metalloproteases (Metalloproteinases)IBA
08/2000
1KB R7785IBA
08/2000
1C-Reactive ProteinIBA
04/2000
1Interleukin-6 (Interleukin 6)IBA
04/2000
1Amikacin (A.M.K)FDA LinkGeneric
02/2000
1Daunorubicin (Cerubidine)FDA LinkGeneric
02/2000
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2000
1CefozopranIBA
02/2000
1Cytarabine (Cytosar-U)FDA LinkGeneric
02/2000
1HLA-DR Antigens (HLA-DR)IBA
01/2000
1HaptoglobinsIBA
01/2000
1Protease Inhibitors (Protease Inhibitor)IBA
01/2000

Therapy/Procedure

3Therapeutics
06/2009 - 01/2000
1Drug Therapy (Chemotherapy)
08/2010
1Hematopoietic Stem Cell Transplantation
02/2006
1Aftercare (After-Treatment)
08/2001
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2000